Quick Answer
Crinetics Pharmaceuticals, Inc. reported Stockholders Equity of $992.08 million for fiscal year 2025.
Crinetics Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $992.08M | -25.1% |
| 2024 | $1.32B | +145.7% |
| 2023 | $539.11M | +70.4% |
| 2022 | $316.33M | -4.7% |
| 2021 | $331.94M | +96.5% |
| 2020 | $168.92M | +44.2% |
| 2019 | $117.14M | -26.9% |
| 2018 | $160.22M | +1166.6% |
| 2017 | -$15.02M | -142.1% |
| 2016 | -$6.20M | -1240.0% |
| 2015 | -$463.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.07B | +28.7% | -8.5% |
| June 30, 2025 | $1.17B | +41.0% | -6.6% |
| March 31, 2025 | $1.25B | +43.3% | -5.3% |
| December 31, 2024 | $1.32B | +145.7% | +59.0% |
| September 30, 2024 | $832.98M | +52.1% | +0.3% |
| June 30, 2024 | $830.76M | +226.9% | -5.0% |
| March 31, 2024 | $874.93M | +212.1% | +62.3% |
| December 31, 2023 | $539.11M | +70.4% | -1.6% |
- Crinetics Pharmaceuticals, Inc. showed a decrease of -25.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Crinetics Pharmaceuticals, Inc.’s stockholders equity has grown by 214372.8% (from -$463.0 thousand to $992.08 million).
- The most recent figure is from Crinetics Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: